Cleared Traditional

K100183 - MODEL MC-180MA MULTI-FREQUENCY BODY COMPOSITION ANALYZER

K100183 is an FDA 510(k) clearance for MODEL MC-180MA MULTI-FREQUENCY BODY COM..., manufactured by Tanita Corp.. The device is a Class 2 Gastroenterology & Urology device with product code MNW cleared through the Traditional 510(k) pathway after a 449-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2011
Decision
449d
Days
Class 2
Risk

K100183 is an FDA 510(k) clearance for the MODEL MC-180MA MULTI-FREQUENCY BODY COMPOSITION ANALYZER. Classified as Analyzer, Body Composition (product code MNW), Class II - Special Controls.

Submitted by Tanita Corp. (Arlington Heights, US). The FDA issued a Cleared decision on April 15, 2011 after a review of 449 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 870.2770 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Gastroenterology & Urology submissions.

View all Tanita Corp. devices

FDA 510(k) Submission Details - K100183

510(k) Number K100183 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 21, 2010
Decision Date April 15, 2011
Days to Decision 449 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
318d slower than avg
Panel avg: 131d · This submission: 449d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MNW Device Classification - Class 2, Special Controls

Product Code MNW Analyzer, Body Composition
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - MNW Analyzer, Body Composition

All 65
Devices cleared under the same product code (MNW) and FDA review panel - the closest regulatory comparables to K100183.
INBODY
K110689 · Biospace Corporation Limited · Aug 2011
BODY ANALYSIS SCALE, MODEL BG 17
K110928 · Shenzhen Healthcare Electronic Technology Co., Ltd. · Jul 2011
TRANSTEK GLASS BODY ANALYZER
K102191 · Zhongshan Transtek Electronics Co., Ltd. · May 2011
ELECTRO SENSOR -BODY COMPOSITION
K103026 · Ld Technology, LLC · Mar 2011
MODIFICATION TO BODYSTAT 1500MDD BODY COMPOSITION MONITORING UNIT
K082254 · Bodystat , Ltd. · Feb 2011
QUADSCAN 4000 BODY BODY COMPOSITION, FLUID & ILLNESS/SEGMENTAL MONITORING UNIT
K082255 · Bodystat , Ltd. · Feb 2011